Innocoll AG (INNL) Doses First Patient in MATRIX-1 Phase 3
Tweet Send to a Friend
Innocoll AG (NASDAQ: INNL) announced that the first patient was dosed in the MATRIX-1 (Multisite Assessment of PosToperative Pain Reduction ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
